In this webinar , you’ll learn when and how to select the right analogs to set the most accurate expectations and payer strategy at launch. For example:
- What are the metrics that payers use to evaluate newly launched drugs?
- Using those metrics, how can manufacturers select an ideal analog from the vast historical launch data that Analytics + PAR provides, to most closely and accurately predict payers’ anticipated adoption of a new drug?
- How can users overlay New to Market policies over analog data to precisely segment slow restrictive payers from fast non-restrictive payers at launch?
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.